Literature DB >> 12237536

Gentamicin sulphate release from a modified commercial acrylic surgical radiopaque bone cement. I. Influence of the gentamicin concentration on the release process mechanism.

Eva Díez-Peña1, Gloria Frutos, Paloma Frutos, José Manuel Barrales-Rienda.   

Abstract

The purpose of the present work was the study of the gentamicin sulphate (GS) release from a commercial acrylic bone cement CMW-1 with the aims of establishing the influence of the slabs preparation as well as the release mechanism and kinetics. The effect of the amount of GS on the release kinetic parameters has been also investigated. In vitro release studies were performed in a buffered saline solution at pH 7.4 and 37 degrees C. The GS concentration was determined using an indirect spectrophotometric method with an o-phthaldialdehyde as a derivatizing reagent. A commercial and three modified samples were tested. The free and fractured surfaces of the GS cement slabs before and after the release studies were observed by means of scanning electron microscopy (SEM). For low GS concentration loading the release was very incomplete because most of the GS beads were encapsulated by the hydrophobic PMMA matrix. A higher amount of antibiotic was released from cement that has a higher amount incorporated. A model and therefore a mechanism of release based on this model have been proposed. It has allowed us to explain the changes in dissolution kinetics of an acrylic matrix type controlled release system up to 12% GS loading. The cumulative amount of GS released M(t)/M(i), was fitted as a function of time. For lower amounts of GS, the regression analysis (R(2)>0.99) revealed that the release is most adequately represented by M(t)/M(i)=b+kt(n), where b represents a burst effect. The goodness of fit decreases as the amount of GS increases. The influence of some other type of release mechanism for higher amounts of GS must be taken into account and a second model for the release, M(t)/M(i)=b+k x [1-exp(-kt)], is proposed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12237536     DOI: 10.1248/cpb.50.1201

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  7 in total

1.  A preliminary study of the release of quaternary ammonium antimicrobial compounds from acrylic bone cement.

Authors:  Manojgna Mathey; Vijaya Surana; Mark Edwards; John W Nicholson
Journal:  J Mater Sci Mater Med       Date:  2009-03-04       Impact factor: 3.896

Review 2.  Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds.

Authors:  Viviana Mouriño; Aldo R Boccaccini
Journal:  J R Soc Interface       Date:  2009-10-28       Impact factor: 4.118

3.  Gelatin Nanoparticles for Targeted Dual Drug Release out of Alginate-di-Aldehyde-Gelatin Gels.

Authors:  Sophie Schrade; Lucas Ritschl; Regine Süss; Pia Schilling; Michael Seidenstuecker
Journal:  Gels       Date:  2022-06-08

4.  Ageing and moisture uptake in polymethyl methacrylate (PMMA) bone cements.

Authors:  Wayne Nishio Ayre; Stephen P Denyer; Samuel L Evans
Journal:  J Mech Behav Biomed Mater       Date:  2013-12-19

5.  The Effectiveness of Local Antibiotics in Treating Chronic Osteomyelitis in a Cohort of 50 Patients with an Average of 4 Years Follow-Up.

Authors:  Andraay H C Leung; Benjamin R Hawthorn; A Hamish R W Simpson
Journal:  Open Orthop J       Date:  2015-07-31

Review 6.  Custom-Made Antibiotic Cement Nails in Orthopaedic Trauma: Review of Outcomes, New Approaches, and Perspectives.

Authors:  Marcin K Wasko; Rafal Kaminski
Journal:  Biomed Res Int       Date:  2015-10-05       Impact factor: 3.411

7.  Treatment of osteomyelitis defects by a vancomycin-loaded gelatin/β-tricalcium phosphate composite scaffold.

Authors:  J Zhou; X G Zhou; J W Wang; H Zhou; J Dong
Journal:  Bone Joint Res       Date:  2018-01       Impact factor: 5.853

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.